Dental Professionals

Introducing OraVerse™

Our premier product is all about creating possibility.

When was the last time you changed the way your patients thought about their dental visit? Now you can give them new possibilities after routine care. As the first and only local dental anesthesia reversal agent, OraVerse allows you to bring patients back to normal sensation and function in approximately half the time.1 And that brings new benefits to your practice.

It’s about time for OraVerse.

  • Proven safe and effective for adults and children aged 6 and older and weighing 33 lbs. or more.
  • Accelerates the reversal of the lingering soft tissue numbness associated with the most widely-used local anesthetics with a vasoconstrictor available in the United States.1
  • Rapidly restores normal function so patients can speak, smile and drink normally in approximately half the time.1
  • Easy to use – a simple injection with a standard dental syringe, just like local anesthetic.



“I anticipate a tremendous interest both from the doctor and the patients in this new product OraVerse.”

Stanley Malamed, DDS
Professor of Anesthesia and Medicine
University of Southern California
School of Dentistry


OraVerse is designed with you and your practice in mind, blending into normal treatment regimens with little additional chair time and no new equipment or training. Plus . . .

  • OraVerse comes in a standard dental cartridge distinctively marked with a green label.
  • OraVerse is easily administered with a standard dental syringe utilizing the same injection site and an identical administration technique as that used for the local anesthetic.
  • OraVerse is used in a straightforward 1:1 ratio to local anesthetic. See full prescribing information for details.





1 Median time to recovery was reduced by 85 minutes (55%) for lower lip and by 83 minutes (62%) for upper lip compared to control. Median time to recovery of normal tongue sensation was reduced by 65 minutes (52%) compared to control. Median time to recovery of normal function was reduced by 60 minutes (50%) in the mandible and by 45 minutes (43%) in the maxilla.